Davidson Investment Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Davidson Investment Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-446,250	Closed	-$7.51M	–	106
2021 Q2	$7.51M	Sell	446,250 -53,953	-11%	-$918K	0.6%	67
2021 Q1	$9.13M	Sell	500,203 -9,597	-2%	-$173K	0.77%	62
2020 Q4	$9.28M	Sell	509,800 -6,754	-1%	-$119K	0.86%	60
2020 Q3	$9.21M	Sell	516,554 -25,474	-5%	-$464K	0.98%	46
2020 Q2	$9.72M	Sell	542,028 -14,669	-3%	-$263K	1.07%	31
2020 Q1	$8.45M	Buy	556,697 +133,768	+32%	+$2.42M	1.09%	34
2019 Q4	$8.34M	Buy	422,929 +4,670	+1%	+$89.3K	0.81%	58
2019 Q3	$7.19M	Sell	418,259 -1,019	-0.2%	-$17.6K	0.75%	60
2019 Q2	$7.42M	Buy	419,278 +191,654	+84%	+$3.49M	0.77%	58
2019 Q1	$4.64M	Buy	+227,624	New	+$4.58M	0.49%	70

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Davidson Investment Advisors's TAK Position: Q3 2021 in Review

Davidson Investment Advisors sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 446,250 shares — an estimated $7.51M sold.

Davidson Investment Advisors first reported a position in TAK in Q1 2019 and held it in 10 quarters. The position peaked at $9.72M in Q2 2020. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

Davidson Investment Advisors reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Davidson Investment Advisors sold 446,250 Takeda Pharmaceutical shares in Q3 2021, an estimated $7.51M.
Davidson Investment Advisors first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 10 quarters.
Davidson Investment Advisors's Takeda Pharmaceutical position peaked at $9.72M in Q2 2020.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Davidson Investment Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.